ID

34422

Description

Powered Echelon Device in VATS Surgery; ODM derived from: https://clinicaltrials.gov/show/NCT01808430

Link

https://clinicaltrials.gov/show/NCT01808430

Keywords

Versions (1)
  1. 1/17/19 1/17/19 -
Copyright Holder

GSK group of companies

Uploaded on

January 17, 2019

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Non-small Cell Lung Cancer (NSCLC) NCT01808430

English

Eligibility Non-small Cell Lung Cancer (NSCLC) NCT01808430

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically confirmed nsclc (up to and including stage ii) for patients undergoing vats lobectomy. for patients undergoing wedge resection for undiagnosed pulmonary nodule or metastasis from crc, a malignant diagnosis may be confirmed post-operatively.
Description

ID.1

Data type

boolean

scheduled for lung resection surgery (lobectomy or wedge resection) involving only one lobe of the lung
Description

ID.2

Data type

boolean

willing to give consent and comply with evaluation and treatment schedule
Description

ID.3

Data type

boolean

at least 18 years of age
Description

ID.4

Data type

boolean

Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
active bacterial infection or fungal infection
Description

ID.5

Data type

boolean

systemic administration (intravenous or oral) of steroids (within 30 days prior to study procedure)
Description

ID.6

Data type

boolean

chemotherapy or radiation therapy for lung cancer may not be performed for 30 days prior to the procedure
Description

ID.7

Data type

boolean

scheduled concurrent surgical procedure other than wedge resection or lobectomy (central venous access - e.g. port placement, mediastinoscopy with lymph node sampling, and vats lymphadenectomy are allowed);
Description

ID.8

Data type

boolean

prior history of vats or open lung surgery
Description

ID.9

Data type

boolean

Back to the top of the page

Similar models

Eligibility Non-small Cell Lung Cancer (NSCLC) NCT01808430

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
histologically confirmed nsclc (up to and including stage ii) for patients undergoing vats lobectomy. for patients undergoing wedge resection for undiagnosed pulmonary nodule or metastasis from crc, a malignant diagnosis may be confirmed post-operatively.
boolean
ID.2
Item
scheduled for lung resection surgery (lobectomy or wedge resection) involving only one lobe of the lung
boolean
ID.3
Item
willing to give consent and comply with evaluation and treatment schedule
boolean
ID.4
Item
at least 18 years of age
boolean
Item Group
C0680251 (UMLS CUI)
ID.5
Item
active bacterial infection or fungal infection
boolean
ID.6
Item
systemic administration (intravenous or oral) of steroids (within 30 days prior to study procedure)
boolean
ID.7
Item
chemotherapy or radiation therapy for lung cancer may not be performed for 30 days prior to the procedure
boolean
ID.8
Item
scheduled concurrent surgical procedure other than wedge resection or lobectomy (central venous access - e.g. port placement, mediastinoscopy with lymph node sampling, and vats lymphadenectomy are allowed);
boolean
ID.9
Item
prior history of vats or open lung surgery
boolean
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial